Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Canada.
Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Canada.
J Thorac Cardiovasc Surg. 2021 Dec;162(6):1744-1752.e7. doi: 10.1016/j.jtcvs.2020.03.003. Epub 2020 Mar 13.
The study objective was to determine the impact on outcome associated with using the second internal thoracic artery as a free compared with an in situ graft among patients who received the first internal thoracic artery as an in situ internal thoracic artery to the left anterior descending artery.
Among 2600 patients who underwent bilateral internal thoracic artery with an in situ internal thoracic artery to the left anterior descending artery, the second internal thoracic artery was used as a free graft bilateral internal thoracic artery in 136 patients and as an in situ graft (in situ bilateral internal thoracic artery) in 2464 patients. One-to-many propensity score matching was performed to produce a cohort of 134 patients with a second free graft internal thoracic artery matched to 2359 patients with a second in situ internal thoracic artery. Early and long-term outcomes including survival, hospital readmission, and repeat revascularization up to a maximum of 25.8 years were compared.
There were no differences between the 2 matched groups' preoperative baseline characteristics and early adverse events. Long-term survival at 5, 10, and 15 years was significantly higher among patients with an in situ bilateral internal thoracic artery compared with patients with a free graft bilateral internal thoracic artery (hazard ratio free graft bilateral internal thoracic artery vs in situ bilateral internal thoracic artery, 1.53; 95% confidence interval, 1.14-2.10; P = .004). However, the long-term risk of readmission to the hospital for cardiovascular reasons and need for repeat revascularization were not significantly different between the 2 matched groups.
In a small, propensity-matched cohort of patients undergoing coronary artery bypass grafting, the use of a second in situ internal thoracic artery was associated with an increase in late survival compared with the use of a second internal thoracic artery as a free graft. However, the risk of late hospital readmission and the need for repeat revascularization were similar.
本研究旨在确定在接受原位左前降支内乳动脉搭桥术的患者中,与原位内乳动脉桥相比,将第二根内乳动脉用作游离移植对结局的影响。
在 2600 例接受双侧内乳动脉与原位左前降支内乳动脉搭桥术的患者中,136 例患者的第二根内乳动脉被用作游离移植,2464 例患者的第二根内乳动脉被用作原位移植(原位双侧内乳动脉)。采用 1:多倾向评分匹配方法,为 134 例接受第二根游离内乳动脉移植的患者匹配了 2359 例接受第二根原位内乳动脉的患者。比较两组患者的早期和长期结局,包括生存、住院再入院和最长 25.8 年的再次血运重建。
两组患者的术前基线特征和早期不良事件无差异。在 5、10 和 15 年的长期生存方面,接受原位双侧内乳动脉的患者明显高于接受游离移植双侧内乳动脉的患者(游离移植双侧内乳动脉与原位双侧内乳动脉的风险比为 1.53;95%置信区间为 1.14-2.10;P=0.004)。然而,两组患者在心血管原因再住院和需要再次血运重建的长期风险无显著差异。
在接受冠状动脉旁路移植术的小、倾向评分匹配患者队列中,与使用第二根内乳动脉作为游离移植相比,使用第二根内乳动脉作为原位内乳动脉桥与晚期生存率的提高相关。然而,晚期再住院和需要再次血运重建的风险相似。